In COVID-19 patients, SARS-CoV-2–specific CD4+ T cells almost exclusively displayed an early differentiated memory phenotype (CD45RA–CD27+, median: 95.1%, IQR: 88.7%–97.4%). The gene discussed is CD4; the disease is COVID-19.